000 01230 a2200313 4500
005 20250514225652.0
264 0 _c20060905
008 200609s 0 0 eng d
022 _a0031-6970
024 7 _a10.1007/s00228-005-0913-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZehngawa, W
245 0 0 _aRelationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients--a comment.
_h[electronic resource]
260 _bEuropean journal of clinical pharmacology
_cJun 2005
300 _a317 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAntihypertensive Agents
_xpharmacology
650 0 4 _aCalcineurin
_xblood
650 0 4 _aCalcineurin Inhibitors
650 0 4 _aCyclosporine
_xadverse effects
650 0 4 _aDrug Interactions
650 0 4 _aEndothelins
_xblood
650 0 4 _aGingival Hypertrophy
_xchemically induced
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xadverse effects
650 0 4 _aKidney Transplantation
773 0 _tEuropean journal of clinical pharmacology
_gvol. 61
_gno. 4
_gp. 317
856 4 0 _uhttps://doi.org/10.1007/s00228-005-0913-x
_zAvailable from publisher's website
999 _c15554492
_d15554492